HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 4,921-4,932 of 27,277
Device study icon
Not Yet RecruitingNCT07369713

Accelerated Intermittent Theta-burst Stimulation (a-iTBS) for depression

Official study title

Efficacy and Safety of Accelerated Intermittent Theta-burst Stimulation (a-iTBS) in Adolescents With Depressive Disorder: A Randomized, Double-Blind, Controlled Pilot Study

This study isn't recruiting yet.

In Chongqing
DepressionDevice studyAges 12–18
Countries
China
Sponsor
First Affiliated Hospital of Chongqing Medical University
Drug study icon
Not Yet RecruitingNCT02129751

Bupropion Hydrobromide for depression

What is this study about?

Researchers are comparing bupropion hydrobromide and placebo, tracking side effects to assess safety in children and adolescents with depression.

This study isn't recruiting yet.

Location not clearly listed
DepressionMedication studyAges 7–17
Countries
Sponsor
Bausch Health Americas, Inc.
Drug study icon
Not Yet RecruitingNCT07555743

Daridorexant for depression

What is this study about?

Researchers are comparing Daridorexant 50 mg and placebo to find out how the approaches affect sleep difficulties in people with depression.

This study isn't recruiting yet.

In Barcelona
DepressionMedication studyAges 18–99
Countries
Spain
Sponsor
Institut d'Investigació Biomèdica de Bellvitge
Behavioral study icon
Not Yet RecruitingACTRN12625000799459

Fly-In-Fly-Out model of Psilocybin-Assisted Therapy (PAT) for depression

Official study title

FIFO-PAT-20: A sequential multiple assignment randomised controlled trial comparing the efficacy and safety of treatment as usual against a Fly-In-Fly-Out (FIFO) model of Psilocybin-Assisted Therapy (PAT) for Major Depressive Disorder (MDD), alongside randomised adjunctive support (virtual-reality vs journalling)

This study isn't recruiting yet.

In Australia
DepressionInterventional studyAges 18–75
Countries
Australia
Sponsor
Monash University
Drug study icon
Not Yet RecruitingACTRN12623000803695

Low-dose Cannabidiol for anxiety

Official study title

Efficacy and Safety of Low-dose Cannabidiol for anxiety in adults: A randomised, double-blind placebo-controlled study

This study isn't recruiting yet.

In Brisbane
AnxietyInterventional studyAges 18–70
Countries
Australia
Sponsor
PharmaCann Pty Ltd
Drug study icon
Not Yet RecruitingNCT07153835

Paliperidone for schizophrenia

Official study title

Evaluation of Efficacy and Safety of Paliperidone Among People With Schizophrenia in Bangladesh

This study isn't recruiting yet.

In Barishal
SchizophreniaMedication studyAges 18–60
Countries
Bangladesh
Sponsor
Sher-E-Bangla Medical College
Device study icon
Not Yet RecruitingNCT07185464

Transcranial Alternating Current Stimulation (tACS) for depression

Official study title

Efficacy and Safety of Transcranial Alternating Current Stimulation (tACS) in Adolescents With First-episode Depression Who Are Drug-naive: A Randomized, Double-blind, Controlled Pilot Study

This study isn't recruiting yet.

In Chongqing
DepressionDevice studyAges 12–18
Countries
China
Sponsor
First Affiliated Hospital of Chongqing Medical University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.